Assignee
LEIUTIS PHARMACEUTICALS LLP
IN·3 granted patents·8 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
11 records- 0170US2024342146A1Triple combination formulations for antiemetic therapyLEIUTIS PHARMACEUTICALS LLP·Filed 2024·Application pending·0 cites
- 0268US12083104B2Triple combination formulations for antiemetic therapyLEIUTIS PHARMACEUTICALS LLP·Filed 2022·Granted Sep 10, 2024·0 cites·20 claims
- 0367US11865180B2Levothyroxine formulations for oral useLEIUTIS PHARMACEUTICALS LLP·Filed 2022·Granted Jan 9, 2024·0 cites·4 claims
- 0464US12409139B2Stable parenteral formulations of duloxetineLEIUTIS PHARMACEUTICALS LLP·Filed 2023·Granted Sep 9, 2025·0 cites·15 claims
- 0561US2023190639A1Formulations of vasopressinLEIUTIS PHARMACEUTICALS LLP·Filed 2023·Application pending·0 cites
- 0659US2022047509A1Stabilized liquid formulation of levothyroxineLEIUTIS PHARMACEUTICALS LLP·Filed 2021·Application pending·0 cites
- 0755US2026069614A1Novel parenteral formulations of cannabidiolLEIUTIS PHARMACEUTICALS LLP·Filed 2023·Application pending·0 cites
- 0853US2025127737A1Novel naproxen sodium preparations for parenteral administrationLEIUTIS PHARMACEUTICALS LLP·Filed 2023·Application pending·0 cites
- 0947US2024307302A1Novel omega 3 carrier preparations for inhalation drug delivery for treating lung inflammationLEIUTIS PHARMACEUTICALS LLP·Filed 2022·Application pending·0 cites
- 1046US2023310465A1Nano lipid carrier system for improving permeation of active ingredientsLEIUTIS PHARMACEUTICALS LLP·Filed 2021·Application pending·0 cites
- 1145US2022409544A1Stable parenteral formulations of duloxetineLEIUTIS PHARMACEUTICALS LLP·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →